|
End-of-day quote
Shanghai S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 5.560 CNY | 0.00% |
|
-12.03% | +61.16% |
| 10-13 | Harbin Pharmaceutical Subsidiary Gets China Approval for Sodium Sulfate API | MT |
| 08-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
Shanghai S.E.CNY
| Markets | Quality | ||
|---|---|---|---|
Shanghai S.E.
| 600664 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 6.99 | 9.49 | 9 |
| Spread/Res. | -20.46% | -41.41% | -38.22% |
| Spread/Supp. | +3.73% | +3.73% | +10.98% |
| Support | 5.36 | 5.36 | 5.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 600664 Stock
- Charts Harbin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
